Roughly 25 to 45 million Americans have irritable bowel syndrome, making it the most common diagnosis in gastroenterology clinics. IBS is a real disorder of gut-brain interaction, not a “wastebasket” label and not a moral failing of stress management. Patients with IBS show measurable differences in gut motility, visceral sensitivity, microbiome composition, and central pain processing compared with controls — even when every blood test looks pristine.
The condition costs the US healthcare system an estimated $30 billion annually in direct and indirect costs, according to data summarized by the International Foundation for Gastrointestinal Disorders. This guide explains the four IBS subtypes, how doctors actually diagnose it, what dietary and pharmacologic approaches have evidence, and when you should rule out something more serious.
What IBS Is — and Isn’t
IBS is a chronic functional GI disorder defined by recurrent abdominal pain associated with changes in bowel habits. Doctors classify it into four subtypes based on stool form: IBS-C (constipation-predominant), IBS-D (diarrhea-predominant), IBS-M (mixed), and IBS-U (unclassified). The older term “spastic colon” is the same condition. About two-thirds of patients are women, and most cases start before age 50.
Critically, IBS does not damage the bowel, does not raise cancer risk, and does not progress to other diseases. That distinguishes it sharply from inflammatory bowel diseases like Crohn’s disease and ulcerative colitis, which involve visible inflammation, ulceration, and structural change. For a broader view of gut and chronic conditions, see our chronic conditions overview.
The Rome IV Diagnostic Criteria
The Rome IV criteria, used worldwide, define IBS as recurrent abdominal pain on average at least one day per week in the past three months, associated with two or more of: relation to defecation, change in stool frequency, or change in stool form. Symptoms must have started at least six months before diagnosis. Doctors don’t need a positive test; they need to fulfill the criteria and exclude red flags.
Red flags that argue against simple IBS and demand workup include onset after age 50, rectal bleeding, nocturnal diarrhea waking the patient from sleep, unintentional weight loss, family history of colon cancer or IBD, and progressive worsening. According to the NIDDK, fecal calprotectin and tissue transglutaminase IgA (for celiac) are reasonable additions to basic labs in most workups.
What Causes IBS
The disorder is multifactorial. Roughly 10 to 15 percent of cases follow an episode of acute gastroenteritis (post-infectious IBS). Visceral hypersensitivity — the gut sending pain signals at lower distension thresholds than normal — is well documented in IBS. Altered gut motility, dysregulation of the gut-brain axis, low-grade immune activation, and shifts in the gut microbiome all contribute.
Anxiety and depression are more common in IBS patients and in some cases precede the GI symptoms by years. That doesn’t mean IBS is “all in your head” — it means the gut and brain share neurotransmitters and stress pathways. Childhood adverse experiences are associated with adult IBS, suggesting a developmental component.
Diet: What Actually Works
The low-FODMAP diet has the strongest evidence. FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) are short-chain carbohydrates that ferment in the small intestine, draw water in, and produce gas. Studies in peer-reviewed gastroenterology journals show 50 to 75 percent of IBS patients improve on a strict elimination phase.
The diet works in three phases: 4 to 6 weeks of strict elimination, 6 to 8 weeks of structured reintroduction to identify personal triggers, and indefinite personalization. It is not meant to be permanent in its strict form — that risks nutritional deficits and microbiome harm. A registered dietitian familiar with FODMAPs is worth the visit.
Other dietary moves with reasonable evidence: soluble fiber (psyllium) for IBS-C and IBS-M, peppermint oil capsules for cramping, limiting caffeine and alcohol, and avoiding very large meals. Insoluble fiber and bran tend to worsen IBS symptoms in many patients. People who feel worse on gluten without a celiac diagnosis may have non-celiac gluten sensitivity, though FODMAPs in wheat (fructans) often explain the symptoms — see our celiac disease guide for the differential.
Medications by Subtype
IBS with constipation
First-line options include polyethylene glycol (Miralax) and soluble fiber. Prescription agents include linaclotide (Linzess), plecanatide (Trulance), lubiprostone (Amitiza), and tenapanor (Ibsrela). All increase intestinal fluid secretion or motility. Response rates run 30 to 40 percent above placebo in pivotal trials.
IBS with diarrhea
Loperamide reduces stool frequency but doesn’t help pain. Eluxadoline (Viberzi) and rifaximin (Xifaxan) are FDA-approved IBS-D therapies. Rifaximin, a poorly absorbed antibiotic, produces durable improvement in about 40 percent of patients after a 14-day course, with a second course available for relapse. Bile acid sequestrants (cholestyramine, colesevelam) help the subset of IBS-D patients who actually have bile acid diarrhea.
Pain and global symptoms
Tricyclic antidepressants at low doses (amitriptyline 10 to 50 mg, nortriptyline 10 to 50 mg) reduce IBS pain in multiple trials, working at gut-brain neuromodulation rather than mood elevation. SSRIs can help patients with prominent anxiety. Antispasmodics like dicyclomine and hyoscyamine offer short-term cramp relief.
Brain-Gut Therapies
Cognitive behavioral therapy (CBT) tailored for IBS produces sustained symptom reduction in roughly 60 percent of patients. Gut-directed hypnotherapy has comparable response rates. Both are now considered evidence-based and are recommended in the ACG IBS guidelines. Apps like Mahana and Nerva have made these therapies more accessible and are FDA-cleared as digital therapeutics.
When to See a Doctor
If symptoms started after age 50, if you see blood, if you wake up at night to use the bathroom, or if you are losing weight without trying, get evaluated. These are not normal IBS features. If you’ve been diagnosed with IBS but standard treatments haven’t helped after several months, it’s worth revisiting the diagnosis — small bowel bacterial overgrowth, microscopic colitis, bile acid diarrhea, and food allergies all mimic IBS and have specific treatments.
Frequently Asked Questions
Is IBS the same as IBD?
No. IBS is a functional disorder with no visible inflammation or structural damage. IBD — Crohn’s disease and ulcerative colitis — involves measurable inflammation, ulceration, and increased cancer risk. Fecal calprotectin testing helps distinguish the two when uncertainty exists.
Can stress cause IBS?
Stress doesn’t cause IBS, but it amplifies symptoms in roughly 60 percent of patients via the gut-brain axis. Many people find their flares track work stress, sleep loss, and travel. CBT and gut-directed hypnotherapy directly address these pathways.
How long does IBS last?
IBS is chronic and tends to wax and wane over decades. Roughly a third of patients enter sustained remission, a third have intermittent symptoms, and a third have persistent symptoms. The condition does not damage the bowel regardless of duration.
What is the difference between IBS-D and IBD?
IBS-D causes diarrhea without bleeding, inflammation, weight loss, or nocturnal symptoms. IBD frequently causes bloody stools, weight loss, and night-time diarrhea, with elevated inflammatory markers. Colonoscopy and calprotectin testing reliably separate them.
What to Do Next
If you suspect IBS, don’t settle for “stress” as an explanation. Confirm the diagnosis with Rome IV criteria, rule out red flags, and try the low-FODMAP elimination phase with dietitian guidance. If diet alone doesn’t work, the prescription menu has expanded substantially since 2015. And if you’ve been on the same antispasmodic for years without improvement, ask about brain-gut neuromodulators — that’s where the real efficacy lives for chronic, refractory IBS.